Seroprevalencija i faktori rizika za infekciju virusom hepatitisa C u ...

31. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral
antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet
2000; 355:887-91.
32. Alter MA. Epidemiology of hepatitis C virus infection. World J Gastroenterol
2007; 13:2436-41.
33. Armstrong GL, Wasley A, simard EP, McQuillan GM, Kuhnert WL, Alter MJ.
The prevalence of hepatitis C virus infection in the United States, 1999
through 2002. Ann Intern Med 2006; 144:705-14.
34. Maio G, d'Argenio P, Stroffolini T, et al. Hepatitis C virus infection and
alanine transaminase levels in the general population: a survey in a
southern Italian town. J Hepatol 2000; 33:116-20.
35. Okayama A, Stuver SO, Tabor E, et al. Incident hepatitis C virus infection in
a community-based population in Japan. J Viral Hepat 2002; 9:43-51.
36. Zhang M, Sun XD, Mark SD, et al. Hepatitis C virus infection, Linxian,
China. Emerg Infect Dis 2005; 11:17-21.
37. Mihaljević I, Feldbauer J, Đelajlija M, Grgičević D. Antibodies to hepatitis C
virus in Croatian blood donors and polytransfused patients. Vox Sang 1992;
63:236-8.
38. Grgicevic D, Balija M, Pirc-Tiljak D, et al. Decreasing risk of viral
transfusion- transmitted diseases in Croatia. Croat Med J 2000; 41(2):191-
6.
39. Trišler Z, Seme K, Poljak M, Čelan-Lucu B, Sakoman S. Prevalence of
hepatitis C and G virus infections among intravenous drug users in
Slovenia and Croatia. Scand J Inf Dis 1999; 31 (18).33-5.
40. Seme K, Poljak M, Begovac J, et al. Low prevalence of hepatitis C virus
infection among human immunodeficiency virus type 1-infected individuals
from Slovenia and Croatia. Acta Virol 2002; 46(2):91-4.
105